Post-approval studies (Phase 4)Study completedNCT00289757
What this trial is testing
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule
Who this might be right for
Hepatitis A
GlaxoSmithKline 78